Editorial: Therapeutic targeting of splicing variants in cancer
Pouya Sarvari,
Karla Rubio,
Karla Rubio,
Stephanie Dobersch,
Aglaia Ntokou,
Aglaia Ntokou,
Verónica Vallejo-Ruiz
Affiliations
Pouya Sarvari
Independent Researcher, Puebla, Mexico
Karla Rubio
International Laboratory EPIGEN, Consejo de Ciencia y Tecnología del Estado de Puebla (CONCYTEP), Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, Mexico
Karla Rubio
Laboratoire IMoPA, Université de Lorraine, CNRS, UMR 7365, Nancy, France
Stephanie Dobersch
Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, United States
Aglaia Ntokou
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, New Haven, CT, United States
Aglaia Ntokou
Yale Department of Genetics, New Haven, CT, United States
Verónica Vallejo-Ruiz
Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla, Mexico